TheEdgeResearch
Home / Stocks / LVAC

LAVA Medtech Acquisition Corp. (LVAC)

NASDAQ Financial Services Shell Companies
$10.43 ▲ +0.00%
Market Cap
$149.9M
Sector
Financial Services
Industry
Shell Companies
Beta
0.00
52-Wk Range
9.94-10.85
CEO
Anthony Natale
Country
US
Currency
USD

LAVA Medtech Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in Waltham, MA, US. The stock last traded at $10.43, up 0.00% on the session, giving a market capitalisation of $149.9M. On trailing twelve-month figures it carries a trailing P/E of 33.65, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
33.65
Price / Sales
0.00
Price / Book
1.29
EV / EBITDA
-95.31
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
0.29
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
—
IPO date
2021-12-17
Headquarters
Waltham, MA, US
About LAVA Medtech Acquisition Corp.

LAVA Medtech Acquisition Corp. (LVAC) currently lacks significant standalone operations. Its primary objective is to secure businesses or assets through various strategic transactions, including mergers, capital stock exchanges, asset acquisitions, stock purchases, or corporate reorganizations. The firm's strategic focus is directed towards opportunities within the healthcare and allied industries. Established in 2021, the company is based in Waltham, Massachusetts, and operates as a subsidiary of LAVA Medtech Sponsor LP.

Comparable companies

LAVA Medtech Acquisition Corp. is most often compared with the following Financial Services names:

BCSABFACBRDFRXBHHLAICULCARENEROSS
More research on LVAC
LVAC technical analysis LVAC TheEdge Score Compare against peers
Open full interactive analysis & DCF →